Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-30

Clinical Trial Update: Turmeric as Treatment in Epilepsy [NA]

View source ↗

Summary

A clinical trial evaluating turmeric as a treatment for epilepsy has been withdrawn, including conditions such as Dravet syndrome, Lennox-Gastaut syndrome, tube…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Turmeric (turmeric)

Snippet

Sponsor: NYU Langone Health | Conditions: Epilepsy, Dravet Syndrome | NA | Status: WITHDRAWN